Ertugliflozin, renoprotection and potential confounding by muscle wasting. Reply to Groothof D, Post A, Gans ROB et al [letter] Letter

Industry Collaboration International Collaboration

cited authors

  • Cherney, David Z. I.; Charbonnel, Bernard; Cosentino, Francesco; Dagogo-Jack, Samuel; McGuire, Darren K.; Pratley, Richard; Shih, Weichung J.; Frederich, Robert; Maldonado, Mario; Pong, Annpey; Cannon, Christopher P.; VERTIS CV Investigators

authors

Publication Date

  • March 3, 2022

webpage

published in

category

keywords

  • Body weight
  • Chronic kidney disease
  • Ertugliflozin
  • Estimated glomerular filtration rate
  • Kidney outcomes
  • Sodium-glucose cotransporter 2 inhibitor

start page

  • 908

end page

  • 911

volume

  • 65

issue

  • 5